ENDP Endo International plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ENDP

Price (delayed)

$0.3677

Market cap

$86.45M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.12

Enterprise value

$6.6B

Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, ...

Highlights
The gross profit has increased by 21% year-on-year
The company's gross margin rose by 15% YoY
Endo International's revenue has increased by 4.5% YoY but it has decreased by 2.2% from the previous quarter
Endo International's equity has plunged by 119% YoY and by 5% from the previous quarter
The EPS has contracted by 19% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Peers: DRRX CARA

Key stats

What are the main financial stats of ENDP
Market
Shares outstanding
235.11M
Market cap
$86.45M
Enterprise value
$6.6B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.03
EV/EBIT
N/A
EV/EBITDA
21.93
EV/Sales
2.25
Earnings
Revenue
$2.93B
EBIT
-$143.84M
EBITDA
$301.09M
Free cash flow
$284.31M
Per share
EPS
-$3.12
Free cash flow per share
$1.22
Book value per share
-$5.61
Revenue per share
$12.52
TBVPS
$12.81
Balance sheet
Total assets
$8.45B
Total liabilities
$9.76B
Debt
$8.11B
Equity
-$1.31B
Working capital
$1.12B
Liquidity
Debt to equity
-6.19
Current ratio
1.81
Quick ratio
1.5
Net debt/EBITDA
21.64
Margins
EBITDA margin
10.3%
Gross margin
59.4%
Net margin
-24.8%
Operating margin
-3.4%
Efficiency
Return on assets
-8.2%
Return on equity
N/A
Return on invested capital
-1.7%
Return on capital employed
-2%
Return on sales
-4.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENDP stock price

How has the Endo International stock price performed over time
Intraday
-5.72%
1 week
5.06%
1 month
1.57%
1 year
-92.48%
YTD
-90.22%
QTD
-84.08%

Financial performance

How have Endo International's revenue and profit performed over time
Revenue
$2.93B
Gross profit
$1.74B
Operating income
-$98.54M
Net income
-$726.74M
Gross margin
59.4%
Net margin
-24.8%
Endo International's operating income has shrunk by 118% YoY
The operating margin has dropped by 117% year-on-year
The gross profit has increased by 21% year-on-year
Endo International's net margin has decreased by 21% from the previous quarter

Growth

What is Endo International's growth rate over time

Valuation

What is Endo International stock price valuation
P/E
N/A
P/B
N/A
P/S
0.03
EV/EBIT
N/A
EV/EBITDA
21.93
EV/Sales
2.25
The EPS has contracted by 19% from the previous quarter
Endo International's equity has plunged by 119% YoY and by 5% from the previous quarter
ENDP's price to sales (P/S) is 94% lower than its 5-year quarterly average of 0.5 and 90% lower than its last 4 quarters average of 0.3
Endo International's revenue has increased by 4.5% YoY but it has decreased by 2.2% from the previous quarter

Efficiency

How efficient is Endo International business performance
Endo International's return on invested capital has shrunk by 129% YoY
The ROS has plunged by 128% YoY
Endo International's ROA has decreased by 22% from the previous quarter

Dividends

What is ENDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENDP.

Financial health

How did Endo International financials performed over time
The company's total assets is 13% lower than its total liabilities
The company's quick ratio rose by 10% QoQ and by 2.7% YoY
The company's total assets fell by 9% YoY and by 3.7% QoQ
Endo International's equity has plunged by 119% YoY and by 5% from the previous quarter
The debt to equity has soared by 55% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.